Pathogenic risk of endogenous retrovirus infection in immunodeficient hosts

Virus Research
Fengmin ZhangHong-xi Gu

Abstract

To investigate the pathogenic risk of endogenous retroviruses (ERVs) infection in immunodeficient hosts, the ERV of N-type ecotropic murine leukemia virus (MuLV) isolated from SL mice, a kind of mice containing considerable infectious ERV particles determined with SC-XC test and developing leukemia spontaneously with average of high frequency of 30% and incubation period of 315days, was inoculated intraperitoneally into newborn CBA nude mice. The distinct marker of splenomegaly for leukemia was observed in 33% of homozygous (nu/nu) and 17% of heterozygous (nu/+) of CBA nude mice with average incubation period of 310days and 432days post-inoculation, respectively. Furthermore, the ERV induced leukemia in both the SL mice and CBA nude mice was identified to be B lymphatic, transplantable and with rearrangement of the Evi-1 locus. The higher induction of leukemia and rearrangement of the Evi-1 locus in CBA nude mice are considered to be dependent on the lower immune status of the hosts. These findings indicate that the ERV could present the host immune dependent leukemogenesis in immunodeficient hosts through the Evi-1 gene rearrangement and suggest that screening of ERVs may be necessary in clinical transplantation or transfusion.

References

Sep 1, 1990·Molecular and Cellular Biology·A M BuchbergN G Copeland
Sep 15, 1988·International Journal of Cancer. Journal International Du Cancer·T OikawaN Kuzumaki
Dec 1, 1969·Journal of Cellular Physiology·Y Ichikawa
Mar 1, 1997·Nature Medicine·C PatienceR A Weiss
Jan 9, 2001·Clinical Microbiology Reviews·R S BonevaL E Chapman
Aug 22, 2003·Reviews in Medical Virology·Saema MagreBirke Bartosch
Oct 5, 2006·Retrovirology·Robin A Weiss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.